Profil
Mikhail Sergeevich Nekrasov currently works at NANOLEK LLC, as Chief Executive Officer and Makiz-Pharma ZAO, as Chairman.
Aktive Positionen von Mikhail Sergeevich Nekrasov
| Unternehmen | Position | Beginn |
|---|---|---|
Makiz-Pharma ZAO
 Makiz-Pharma ZAO Pharmaceuticals: MajorHealth Technology Makiz-Pharma ZAO manufactures pharmaceutical products. Its main products are medicines for cardiovascular problems and gastroenterology. The company was founded in 2001 and is headquartered in Moscow, Russia. | Vorsitzender | - |
Nanolek LLC
 Nanolek LLC Pharmaceuticals: MajorHealth Technology Nanolek LLC provides biotechnological services. Its project provides integrated pharmaceutical production facilities with the usage of a new technology platform that allows receiving innovative vaccines and pharmaceuticals based on nanotechnology and nanomaterials. The firm's products include Nanovaccines and other biomedical products, Organogel-based ointments and gels, and Solid dosage forms. The company was Founded on April 28, 2011 and is headquartered in Moscow, Russian Federation. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Makiz-Pharma ZAO
Makiz-Pharma ZAO Pharmaceuticals: MajorHealth Technology Makiz-Pharma ZAO manufactures pharmaceutical products. Its main products are medicines for cardiovascular problems and gastroenterology. The company was founded in 2001 and is headquartered in Moscow, Russia. | Health Technology |
Nanolek LLC
Nanolek LLC Pharmaceuticals: MajorHealth Technology Nanolek LLC provides biotechnological services. Its project provides integrated pharmaceutical production facilities with the usage of a new technology platform that allows receiving innovative vaccines and pharmaceuticals based on nanotechnology and nanomaterials. The firm's products include Nanovaccines and other biomedical products, Organogel-based ointments and gels, and Solid dosage forms. The company was Founded on April 28, 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
